Ravi Kiron

Ravi Kiron

Consultant / Adviseur bij
ShangPharma Innovation, Inc.
66 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

Ravi Kiron is the founder of C2N Diagnostics LLC, which was founded in 2007.
He held the title of Chief Business Officer from 2007 to 2008.
Dr. Kiron's current jobs include Head & BioPharma External Innovation at EMD Serono, Inc. since 2017, and Executive-in-Residence at ShangPharma Innovation, Inc. since 2017.
Dr. Kiron's former jobs include Executive Director at Johnson & Johnson from 2004 to 2007, Managing Director at Adjuvant Partners LLC from 2008 to 2011, and Global Head, Strategic Analysis & KM at Pfizer Inc. from 1991 to 2004.
He also served as Chief Business Officer at KineMed, Inc. and as a Business Development Advisor at Aduro BioTech, Inc. from 2010 to 2012.
Dr. Kiron's education includes an MBA from Rensselaer Polytechnic Institute in 1998, a doctorate from the Indian Institute of Science in 1986, and undergraduate and graduate degrees from the University of Mumbai in 1979 and 1981 respectively.

Actieve functies van Ravi Kiron

BedrijvenFunctieBegin
Consultant / Adviseur 01-02-2017
Corporate Officer/Principal 01-06-2017

Eerdere bekende functies van Ravi Kiron

BedrijvenFunctieEinde
CHINOOK THERAPEUTICS, INC. Consultant / Adviseur 01-04-2012
Adjuvant Partners LLC
Corporate Officer/Principal 01-01-2011
Oprichter 01-07-2008
JOHNSON & JOHNSON Corporate Officer/Principal 01-01-2007
PFIZER INC. Corporate Officer/Principal 01-01-2004
Ervaring van Ravi Kiron in detail bekijken

Opleiding van Ravi Kiron

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

94

Eerstegraads connecties

11

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit11

Health Technology

Health Technology

Commercial Services

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Finance

Adjuvant Partners LLC

  1. Beurs
  2. Insiders
  3. Ravi Kiron